Category: Finance
-
“Dark Genome” Drug Discoverer Gains $37M in Early Funds
19 Oct. 2022. A biotechnology enterprise discovering new drugs from non-protein coding regions of the genome is raising €37.5 million ($US 36.6 million) in venture funds. Nucleome Therapeutics Ltd. in Oxford, U.K. is a three year-old business spun-off from genetic research labs at University of Oxford medical school. Nucleome Therapeutics is seeking new treatments for…
-
Infographic – US Biotech Venture Funds Fall in Q3
Venture funds for U.S. biotechnology and pharmaceutical start-ups declined in the third quarter of 2022 from the 2021 record pace, but remain on track for historic highs.
-
Hydrogel Biomaterials Company Raises $3M in Early Funds
A developer of bioactive hydrogels as alternatives to animal models for drug discovery and clinical lab tests is raising $3 million in its first venture round.
-
Start-Up to Manufacture, Supply Practical Radiation Drugs
A new company formed by a technology venture investor and the Mayo Clinic aims to produce and supply more readily available radiation drug therapies.
-
Infographic – Sharp Drop in Q3 Venture Funds
Total venture investing worldwide dropped to $81 billion in July to September 2022, a decline of $40 billion or one-third compared to the second quarter of the year.
-
Nasal Spray Vaccines Get CEPI, NIH Funding
A developer of infectious disease vaccines is gaining funds for new nasal sprays protecting against a range of coronaviruses and the sexually-transmitted disease gonorrhea.
-
Infographic – Biotech Index Q3 Rollercoaster
For the year-to-date, as noted in today’s chart, NBI shows a general decline, losing more than one-fifth of its value since January.
-
Start-Up Developing Efficient RNA Process, Raises $12M
A company formed earlier this year is commercializing a more efficient process for making synthetic RNA molecules and raising $12 million in seed funds.
-
NIH Funds Decentralized Rare Disease Data Network
A start-up company is building a secure decentralized network of genomic and other medical data on rare diseases, funded by a fast-track award from an NIH agency.
-
Challenge Seeks Animal-Free Testing for Precision Meds.
A charitable foundation promoting research on human longevity unveiled a challenge competition to develop animal-free testing for personalized medicine.